 |
|
Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis
Sang Hoon Lee, Yoomi Yeo, Tae-Hyung Kim, Hong Lyeol Lee, Jin Hwa Lee, Yong Bum Park, Jong Sun Park, Yee Hyung Kim, Jin Woo Song, Byung Woo Jhun, Hyun Jung Kim, Jinkyeong Park, Soo-Taek Uh, Young Whan Kim, Dong Soon Kim, Moo Suk Park,
Tuberc Respir Dis. 2019;82(2):102-117. Published online 2019 Feb 28 DOI: https://doi.org/10.4046/trd.2018.0091
|
|
Citations to this article as recorded by
 Nitrogen dioxide increases the risk of disease progression in idiopathic pulmonary fibrosis
Hee‐Young Yoon, Sun‐Young Kim, Ok‐Jin Kim, Jin Woo Song
Respirology.2023; 28(3): 254. CrossRef Association of citrullination with the progression of aortic stenosis
Ah-Ram Kim, Eunhye Ji, Sahmin Lee, Seokchan Hong, Dae-Hee Kim, Jong-Min Song, Duk-Hyun Kang, Jae-Kwan Song
Scientific Reports.2023;[Epub] CrossRef Impact of the revised definition on incidence and outcomes of acute exacerbation of idiopathic pulmonary fibrosis
Jung-Wan Yoo, Jehun Kim, Jin Woo Song
Scientific Reports.2022;[Epub] CrossRef Allocation of Donor Lungs in Korea
Hye Ju Yeo
Journal of Chest Surgery.2022; 55(4): 274. CrossRef Outcomes of Patients on the Lung Transplantation Waitlist in Korea: A Korean Network for Organ Sharing Data Analysis
Hye Ju Yeo, Dong Kyu Oh, Woo Sik Yu, Sun Mi Choi, Kyeongman Jeon, Mihyang Ha, Jin Gu Lee, Woo Hyun Cho, Young Tae Kim
Journal of Korean Medical Science.2022;[Epub] CrossRef Efficacy and safety of traditional Chinese medicine treatment for idiopathic pulmonary fibrosis: An exploratory, randomized, double-blinded and placebo controlled trial
Jiansheng Li, Xue-qing Yu, Yang Xie, Shu-guang Yang, Limin Zhao, Miao Zhou, Yong Meng
Frontiers in Pharmacology.2022;[Epub] CrossRef Blood Krebs von den Lungen-6 levels predict treatment response to antifibrotic therapy in patients with idiopathic pulmonary fibrosis
Myeong Geun Choi, Sun Mi Choi, Jae Ha Lee, Joong-Yub Kim, Jin Woo Song
Respiratory Research.2022;[Epub] CrossRef Pharmacological treatment of idiopathic pulmonary fibrosis and fibrosing interstitial lung diseases: current trends and future directions
Won-Il Choi
Precision and Future Medicine.2021; 5(1): 31. CrossRef Current and future treatment for idiopathic pulmonary fibrosis
Won-Il Choi
Journal of the Korean Medical Association.2021; 64(4): 256. CrossRef Reliability of Portable Spirometry Performed in the Korea National Health and Nutrition Examination Survey Compared to Conventional Spirometry
Hye Jung Park, Chin Kook Rhee, Kwang Ha Yoo, Yong Bum Park
Tuberculosis and Respiratory Diseases.2021; 84(4): 274. CrossRef All-cause mortality of patients with idiopathic pulmonary fibrosis: a nationwide population-based cohort study in Korea
Sung Jun Ko, Sun Mi Choi, Kyung-Do Han, Chang-Hoon Lee, Jinwoo Lee
Scientific Reports.2021;[Epub] CrossRef The Value of 18F-FDG PET/CT in Evaluating Disease Severity and Prognosis in Idiopathic Pulmonary Fibrosis Patients
Hee-Young Yoon, Suk Hyun Lee, Sejin Ha, Jin-Sook Ryu, Jin Woo Song
Journal of Korean Medical Science.2021;[Epub] CrossRef Idiopathic pulmonary fibrosis: Molecular mechanisms and potential treatment approaches
Daniel S. Glass, David Grossfeld, Heather A. Renna, Priya Agarwala, Peter Spiegler, Lora J. Kasselman, Amy D. Glass, Joshua DeLeon, Allison B. Reiss
Respiratory Investigation.2020; 58(5): 320. CrossRef Associations between gastro-oesophageal reflux disease and a range of diseases: an umbrella review of systematic reviews and meta-analyses
JinJing Tan, Liqun Li, Xiaoyan Huang, Chengning Yang, Xue Liang, Yina Zhao, Jieru Xie, Ran Chen, Daogang Wang, Sheng Xie
BMJ Open.2020; 10(12): e038450. CrossRef
|